Cybin (HELP) Total Liabilities (2021 - 2026)
Cybin (HELP) posted quarterly Total Liabilities of $251.2 million for Q1 2026, up 39.35% year-on-year from $180.2 million in Q1 2025, and up 1452.52% on a QoQ basis from $16.2 million in Q4 2025.
Cybin (HELP) Total Liabilities (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Total Liabilities for 6 consecutive years, with $251.2 million the latest figure, recorded in Q1 2026.
- Quarterly Total Liabilities rose 39.35% year-over-year to $251.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $431.4 million (up 139.35% YoY) and the FY2026 annual result came in at $251.2 million, up 35.01% from the prior year.
- Total Liabilities grew to $251.2 million in Q1 2026 per HELP's latest filing, from $16.2 million in the prior quarter.
- Over the last five years, Total Liabilities for HELP reached as high as $251.2 million in Q1 2026 and fell as low as $3.2 million in Q4 2022.
- A 5-year average of $40.3 million and a median of $6.9 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities slumped 48.79% — and 2025, when it soared 2305.58%.
- Year by year, Total Liabilities stood at $3.2 million in 2022, then soared by 94.05% to $6.2 million in 2023, then surged by 52.5% to $9.5 million in 2024, then soared by 69.85% to $16.2 million in 2025, then jumped by 1452.52% to $251.2 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $251.2 million, $16.2 million, and $42.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 251.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251.17 Mn |
| Dec 31, 2025 | 16.18 Mn |
| Sep 30, 2025 | 42.25 Mn |
| Jun 30, 2025 | 59.05 Mn |
| Mar 31, 2025 | 180.24 Mn |
| Dec 31, 2024 | 9.53 Mn |
| Sep 30, 2024 | 5.40 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | 7.49 Mn |
| Dec 31, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 6.87 Mn |
| Feb 28, 2023 | 3.34 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Dec 31, 2021 | 4.81 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Jun 30, 2021 | 5.34 Mn |
| Mar 31, 2021 | 4.74 Mn |